B-cell Activating Factor (BAFF) and A Proliferation-Inducing Ligand (APRIL) levels, which are prognostic markers of MG, were found reduced suggesting that B-cells were eliminated as both markers correlate with survival and proliferation of B-cells. This evidence concerns the gene TNFSF13 and myasthenia gravis.